 |
Previous Article
The Journal of Neuroscience, September 1, 2002, 22(17):7825-7833
Abnormal Cerebellar Signaling Induces Dystonia in Mice
Carolyn E.
Pizoli1,
H.
A.
Jinnah2,
Melvin L.
Billingsley1, and
Ellen J.
Hess2
1 Department of Pharmacology, Pennsylvania State
University College of Medicine, Hershey, Pennsylvania 17033, and
2 Department of Neurology, Johns Hopkins University School
of Medicine, Baltimore, Maryland 21287
Dystonia is a relatively common neurological syndrome characterized
by twisting movements or sustained abnormal postures. Although the
basal ganglia have been implicated in the expression of dystonia,
recent evidence suggests that abnormal cerebellar function is
also involved. In these studies, a novel mouse model was developed to
study the role of the cerebellum in dystonia. Microinjection of low
doses of kainic acid into the cerebellar vermis of mice elicited
reliable and reproducible dystonic postures of the trunk and limbs. The
severity of the dystonia increased linearly with kainate dose.
Kainate-induced dystonia was blocked by the glutamatergic antagonist
1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide and reproduced by domoic acid microinjection, suggesting that the
induction of dystonia is dependent on glutamatergic activation in this model. The abnormal movements were not associated
with kainate-induced seizures, because EEG recordings showed no
epileptiform activity during the dystonic events. Neuronal activation,
as assessed by in situ hybridization for
c-fos, revealed c-fos mRNA expression in
the cerebellum, locus ceruleus, and red nucleus. In contrast, regions
associated with epileptic seizures, such as the hippocampus, did not
exhibit increased c-fos expression after cerebellar
kainate injection. Furthermore, in transgenic mice lacking Purkinje
cells, significantly less dystonia was induced after kainic acid
injection, implicating Purkinje cells and the cerebellar cortex in this
model of dystonia. Together, these data suggest that abnormal
cerebellar signaling produces dystonia and that the cerebellum should
be considered along with the basal ganglia in the pathophysiology of
this movement disorder.
Key words:
dystonia; cerebellum; red nucleus; kainic acid; Purkinje
cell; glutamate; movement disorder; transgenic; c-fos
Copyright © 2002 Society for Neuroscience 0270-6474/02/22177825-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. Argyelan, M. Carbon, M. Niethammer, A. M. Ulug, H. U. Voss, S. B. Bressman, V. Dhawan, and D. Eidelberg
Cerebellothalamocortical Connectivity Regulates Penetrance in Dystonia
J. Neurosci.,
August 5, 2009;
29(31):
9740 - 9747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Neychev, X. Fan, V. I. Mitev, E. J. Hess, and H. A. Jinnah
The basal ganglia and cerebellum interact in the expression of dystonic movement
Brain,
September 1, 2008;
131(9):
2499 - 2509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Simonyan, F. Tovar-Moll, J. Ostuni, M. Hallett, V. F. Kalasinsky, M. R. Lewin-Smith, E. J. Rushing, A. O. Vortmeyer, and C. L. Ludlow
Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study
Brain,
February 1, 2008;
131(2):
447 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Delmaire, M. Vidailhet, A. Elbaz, F. Bourdain, J. P. Bleton, S. Sangla, S. Meunier, A. Terrier, and S. Lehericy
Structural abnormalities in the cerebellum and sensorimotor circuit in writer's cramp
Neurology,
July 24, 2007;
69(4):
376 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Jinnah and E. J. Hess
A new twist on the anatomy of dystonia: The basal ganglia and the cerebellum?
Neurology,
November 28, 2006;
67(10):
1740 - 1741.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Le Ber, F. Clot, L. Vercueil, A. Camuzat, M. Viemont, N. Benamar, P. De Liege, A. M. Ouvrard-Hernandez, P. Pollak, G. Stevanin, et al.
Predominant dystonia with marked cerebellar atrophy: A rare phenotype in familial dystonia
Neurology,
November 28, 2006;
67(10):
1769 - 1773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Buschdorf, L. Li Chew, B. Zhang, Q. Cao, F.-Y. Liang, Y.-C. Liou, Y. T. Zhou, and B. C. Low
Brain-specific BNIP-2-homology protein Caytaxin relocalises glutaminase to neurite terminals and reduces glutamate levels.
J. Cell Sci.,
August 15, 2006;
119(Pt 16):
3337 - 3350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Sanger
Pathophysiology of Pediatric Movement Disorders
J Child Neurol,
January 1, 2003;
18(1_suppl):
S9 - S24.
[Abstract]
[PDF]
|
 |
|
|

|